https://www.selleckchem.com/pr....oducts/golvatinib-e7
epository https//github.uconn.edu/mldrugdiscovery/OctSurf.The androgen receptor (AR), a family of nuclear receptor proteins, stimulates the transcription of androgen-responsive genes. As its abnormal activation can cause the progression of prostate cancer, numerous types of ligands for AR have been developed as promising antagonists for the treatment of prostate cancer. We previously investigated the specific interactions between AR and nine types of existing non-steroidal ligands, using molecular simulations based on molecular
Like
Comment
Share
